These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12075819)
21. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice. Rabinovich S; Shaw BD; Bryant T; Donta ST J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179 [No Abstract] [Full Text] [Related]
22. Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model. Khan MA; Faisal SM; Mohammad O J Drug Target; 2006 May; 14(4):233-41. PubMed ID: 16777682 [TBL] [Abstract][Full Text] [Related]
23. Polysaccharide-coated liposomal amphotericin B for the treatment of murine pulmonary candidiasis. Miyazaki T; Kohno S; Sasayama K; Inoue Y; Hara K; Ogasawara M; Sato T; Sunamoto J Tohoku J Exp Med; 1992 Nov; 168(3):483-90. PubMed ID: 1304655 [TBL] [Abstract][Full Text] [Related]
24. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024 [TBL] [Abstract][Full Text] [Related]
25. Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo. Cacciapuoti A; Gurnani M; Halpern J; Norris C; Patel R; Loebenberg D Antimicrob Agents Chemother; 2005 Feb; 49(2):638-42. PubMed ID: 15673745 [TBL] [Abstract][Full Text] [Related]
26. Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis. Garcia A; Adler-Moore JP; Proffitt RT Antimicrob Agents Chemother; 2000 Sep; 44(9):2327-32. PubMed ID: 10952575 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of T-2307, a novel arylamidine, against ocular complications of disseminated candidiasis in mice. Abe M; Nakamura S; Kinjo Y; Masuyama Y; Mitsuyama J; Kaku M; Miyazaki Y J Antimicrob Chemother; 2019 May; 74(5):1327-1332. PubMed ID: 30753506 [TBL] [Abstract][Full Text] [Related]
28. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Zarif L; Graybill JR; Perlin D; Najvar L; Bocanegra R; Mannino RJ Antimicrob Agents Chemother; 2000 Jun; 44(6):1463-9. PubMed ID: 10817694 [TBL] [Abstract][Full Text] [Related]
29. Potential use of tuftsin in treatment of candida peritonitis in a murine model. Levy R; Kain Z; Chaimovitz C; Fridkin M; Segal S; Alkan M J Biol Regul Homeost Agents; 1989; 3(2):71-8. PubMed ID: 2554684 [TBL] [Abstract][Full Text] [Related]
30. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis. Xin H; Rosario-Colon JA; Eberle K mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668 [TBL] [Abstract][Full Text] [Related]
31. Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Lopez-Berestein G; Mehta R; Hopfer R; Mehta K; Hersh EM; Juliano R Cancer Drug Deliv; 1983; 1(1):37-42. PubMed ID: 6544116 [TBL] [Abstract][Full Text] [Related]
32. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient]. Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216 [No Abstract] [Full Text] [Related]
33. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model. Khan MA; Aljarbou AN; Khan A; Younus H Int J Biol Macromol; 2015 May; 76():203-8. PubMed ID: 25709021 [TBL] [Abstract][Full Text] [Related]
34. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion. Souza LC; Campa A J Antimicrob Chemother; 1999 Jul; 44(1):77-84. PubMed ID: 10459813 [TBL] [Abstract][Full Text] [Related]
36. Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis. Adler-Moore JP; Olson JA; Proffitt RT J Antimicrob Chemother; 2004 Dec; 54(6):1096-102. PubMed ID: 15509617 [TBL] [Abstract][Full Text] [Related]
37. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of intrinsic and acquired immune cells infiltration in kidney and spleen of the mice infected with systemic candidiasis and treated with chloroform fraction of Zataria Multiflora Boiss. Bayat M; Hassannejad N; Ghazanfari H Microb Pathog; 2018 Jan; 114():444-448. PubMed ID: 29183758 [TBL] [Abstract][Full Text] [Related]
39. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. Cenci E; Mencacci A; Del Sero G; Fé d'Ostiani C; Montagnoli C; Bacci A; Bistoni F; Romani L J Chemother; 1998 Apr; 10(2):160-3. PubMed ID: 9603646 [No Abstract] [Full Text] [Related]
40. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]